Status:
UNKNOWN
Epidemiological Study on Asymptomatic Infections and Mild Illness With Covid-19 in Shanghai
Lead Sponsor:
Ruijin Hospital
Conditions:
COVID-19
Eligibility:
All Genders
Brief Summary
this study is to clarify the epidemiological characteristics of Omicron variant infected persons in Shanghai, such as distribution characteristics, host and clinical characteristics, disease outcome a...
Eligibility Criteria
Inclusion
- SARS-Cov-2 RNA positive.
- asymptomatic or mild clinical manifestation.
- informed consent signed.
Exclusion
- informed consent rejected.
Key Trial Info
Start Date :
April 2 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 31 2022
Estimated Enrollment :
10000 Patients enrolled
Trial Details
Trial ID
NCT05375786
Start Date
April 2 2022
End Date
July 31 2022
Last Update
May 17 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ruijin hospital
Shanghai, Shanghai Municipality, China, 200025